Optimized sgRNA design to maximize activity and minimize off-target effects of CRISPR-Cas9
From MaRDI portal
Publication:68752
DOI10.1038/NBT.3437WikidataQ35896845 ScholiaQ35896845MaRDI QIDQ68752FDOQ68752
Authors: John G Doench, Nicolo Fusi, Meagan E Sullender, Mudra Hegde, Emma W Vaimberg, Katherine F Donovan, Ian Smith, Zuzana Tothova, Craig Wilen, Robert Orchard, Herbert W Virgin, Jennifer Listgarten, David E Root 
Publication date: 18 January 2016
Published in: Nature Biotechnology (Search for Journal in Brave)
Cited In (1)
This page was built for publication: Optimized sgRNA design to maximize activity and minimize off-target effects of CRISPR-Cas9
Report a bug (only for logged in users!)Click here to report a bug for this page (MaRDI item Q68752)
